MAR 06, 2018 10:00 PM PST

Increasing Endogenous Cannabinoid Levels May Reduce Neuropathic Orofacial Pain

WRITTEN BY: Mauri Brueggeman

Neurotransmitter systems in the body have incredible functionality and versatility.  One such system is the Endocannabinoid System (ES).  Studies have begun examining the complex interaction of this system in the body and within numerous physiological processes. Recent research has shown the usefulness of cannabis compounds, specifically cannabinoids, in the treatment of neuropathic pain through ES complex signalling mechanisms.  Many have focused their attention solely on phytocannabinoids found in the cannabis plant or endocannabinoids found in the human body.  Still others have explored the pathophysiological process to better understand neuropathic pain.

The process of feeling or sensing pain involves the endocannabinoid system and researchers have found cannabis and phytocannabinoids can reduce neuropathic pain symptoms.  Some groups have chosen to evaluate options for reducing pain in specific types of neuropathies.  One area of active research is in neuropathic orofacial pain (NOP). 

There are a multitude of causes for NOP and the underlying physiological process of why that pain occurs is mostly unknown so identifying therapeutic options is challenging.  Researchers in Europe began looking that this years ago but a new article in Journal of Oral Science’s March 2018 publication provides new insights into the possibilities of pain management for orofacial pain.

The group began examining how endocannabinoids (produced in the body) affect pain receptors and designed an animal study to manipulate endocannabinoids in vivo and evaluate their perceived effects on NOP.  Kamimura, et al., (J Oral Sci) postulated that the endocannabinoid 2-arachydonoylglycerol (2-AG) present in the brain could reduce the pain signals generated by orofacial nerve injury or damage.  2-AG is degraded by enzymes in vivo causing pain signals to chronically persist.  The researchers introduced an inhibition factor, JZL184, which prevents the enzymatic action of monoacylglycerol (MAGL).  MAGL breaks down 2-AG in vivo.

Upon completion of this study, Kamimura, et al. found that by restricting degradation of 2-AG, therefore leaving increased amounts of endogenous 2-AG in the brain, orofacial pain was attenuated.  This mechanism shows promise for future therapeutic treatment options for NOP.  Additional challenges are the differences between animal studies and translation to human trials; however, because the compounds used in the study are endogenous normally, perhaps converting the design for clinical trials may not be quite as challenging. 

 

 

 

Sources: Journal of Oral SciencePain, International Journal of Biochemistry and Cell Biology,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
APR 23, 2020
Cannabis Sciences
No Difference Between Indica and Sativa Cannabis Strains
APR 23, 2020
No Difference Between Indica and Sativa Cannabis Strains
Cannabis growers and sellers have defined different strains of cannabis as ‘indica’ or ‘sativa’ ...
JUN 03, 2020
Cannabis Sciences
CBD Oil May Treat and Prevent Acne
JUN 03, 2020
CBD Oil May Treat and Prevent Acne
Cannabidiol (CBD) is a compound found in cannabis. Known for its relaxing effects, some research also suggests that it m ...
JUN 10, 2020
Cannabis Sciences
Should We Be Concerned About Cannabis Poisoning in Minors?
JUN 10, 2020
Should We Be Concerned About Cannabis Poisoning in Minors?
The Canadian federal government began legalizing aspects of recreational marijuana use in October 2018, so researchers a ...
JUN 15, 2020
Cannabis Sciences
Prenatal Cannabis Exposure Does Not Cause Brain Damage in Children
JUN 15, 2020
Prenatal Cannabis Exposure Does Not Cause Brain Damage in Children
Parents and their children often face separation and other punishments due to the idea that prenatal cannabis exposure c ...
JUN 20, 2020
Cannabis Sciences
Prolonged Cannabis Use May Prevent Migraines
JUN 20, 2020
Prolonged Cannabis Use May Prevent Migraines
Between 1% and 2% of the world's population suffers from chronic migraines. Researchers from Israel have now found t ...
JUL 30, 2020
Health & Medicine
Navy Goes Overboard on Hemp Ban for Sailors and Marines
JUL 30, 2020
Navy Goes Overboard on Hemp Ban for Sailors and Marines
It may be a federally legal crop, but the Sailors and Marines of the US navy have been told they cannot use hemp in any ...
Loading Comments...